CHICAGO (April 9, 2013)—The $1 million da Vinci robot is hot in operating rooms these days, but it’s under new scrutiny.
The U.S. Food and Drug Administration is looking into an increase in reported problems including deaths during robotic surgeries.
The agency’s medical device database lists dozens of problems and at least five deaths since early last year.
The FDA is trying to figure out if there's a real connection with the robot.
Surgeons who use the robotic system say it leads to shorter hospital stays for some patients and is safer than surgery using big incisions, but critics argue that robotic surgeries cost more, and that newer doesn't always mean better.